Initially, EVs were proposed to release for getting rid of cellular waste. However, recent data revealed that EVs are an alternative way of maintaining cellular homeostasis. 9 Importantly, these vesicles --
| GE NERATION AND PROPERTIES OF EXTRACELLUAR VESICLE (EV)
Extracellular vesicles are secreted by most cell types under both physiological and pathological conditions. However, when cells are exposed to stress conditions, such as inflammation, lysosome dysfunction, endoplasmic reticulum stress, hypoxia or irradiation, it may lead to an increase in exosome release. It is demonstrated that tumour cells increase the release of MVs with enhanced procoagulant activity. 2 Hypoxia induced more exosomes production in tumour cells and play important roles in tumour angiogenesis, invasion, metastasis and the immune system. 3 It is likely that cells subjected to stress increase its communication with adjacent cells via the release of EVs. 4 During secretion, EVs contain endogenous substances from the parent cells, including RNAs, DNAs, proteins and lipids. 5, 6 Comparative study also revealed that the component varied in different pupa-
tions of EVs. While large EVs (L-EV) and small EVs (S-EV) (exosomes)
purified from the same cells contained similar amounts of protein, DNA was more abundant in L-EV, despite S-EVs being more numerous. 7 Differences in the abundance levels of the EV miRNAs could discriminate between the three EV populations, apoptotic bodies, microvesicles and exosomes. 8 The varied cargoes of different populations of EVs may suggest their different functional roles.
are believed to play a role in intercellular communication and have been involved in numerous cellular physiological and pathological processes ( Figure 1 ).
| EVs were released to maintain cell homeostasis
Multivesicular bodies can either be directed to lysosomes for degradation or transported to the plasma membrane for exosome release. 10 Thus, exosomes were a protein quality control pathway in addition to degradation-based approach, maintaining protein homeostasis by exporting misfolded proteins through excretion route. 11 
EVs and cytokines
In addition to be secreted in soluble free format, cytokines are also imported into EVs and released into extracellular space. For instance, interleukin-1β (IL-1β) is a secreted protein that lacks a signal peptide
and cannot be secreted in traditional pathway. Thus, IL-1β was found to be secreted in a protected form being packaged and secreted via both exosomes and MVs. 27, 28 A recent report found that a wide variety of cytokines were encapsulated into EVs as observed in different in vitro, ex vivo and in vivo systems. Importantly, EVs carrying cytokines are more stable than free cytokines and are biologically active upon interacting with sensitive cells, 29 while free cytokines are usually unstable and have very short half-life in plasma. 30 EVs-associated cytokines might be destined for signalling processes at sites distant to the local inflammatory lesion.
EVs and microRNA
Among EVs, exosomes are the fraction that is enriched in genetic material, mostly non-coding RNAs. In addition to bounding to protective proteins, such as high-density lipoprotein and argonaute protein, miRNAs were packaged into protective exosomes. 22 Since the first study reported in 2007, 31 increasing studies showed that exosomes carry miRNA and can transfer functionality to a recipient cell in different disease status. Adipose tissue macrophages secreted exosomes containing miRNA cargo, which can be transferred to insulin target cell types with robust effects on cellular insulin action. 32 Another aspect of EV-associated miRNAs that might be of importance, is that miRNA in exosomes may activate TLRs as paracrine agonists and contribute to inflammation. TLR7 and TLR8 are located in intracellular endosomes, Fabbri et al demonstrated miRNAs in cancer-released exosomes could reach and bind TLR7 and TLR8 in a "receiving" cell. 33 A number of possible mechanisms involving EV-mediated transfer of functional molecules that trigger pro-repair pathways in target cells have been proved. 35 Gupta et al identified a distinct type of early apoptotic EVs with specific mitogenic activity, which are found in damaged mouse glomeruli and thus might have regenerative effects in the kidney. 36 Interestingly, exosomes from human umbilical cord MSC inhibited STZ-induced β-cell apoptosis and restored the insulin secreting function of T2DM. In rat models, exosomes from hucMSC can alleviate T2DM through reversing peripheral insulin resistance and relieving β-cell destruction. 37 Endogenous annexin A1 (ANXA1) is released as a component of EVs derived from intestinal epithelial cells, and these ANXA1-containing EVs activated wound repair circuits. 
| Tubular epithelial cell-derived EVs and the communication routes
Tubule epithelial cells are the most populous cell type in the kidney, and carry out diverse regulatory and endocrine functions in normal kidney physiology as well as pathogenesis of kidney disease. 39 Interestingly, recent studies indicated that external insults such as hypoxia, proteinuria or physical wounding triggered the release of EVs from tubular epithelial cells (TECs) carrying specific cargo. In condition of hypoxia, hypoxia-inducible factor-1 (HIF-1)
promoted exosome production in TECs. 40 Importantly, differential expression levels of both known and unique miRNA and protein species from exosomes were found. 41 
| Tubular-interstitial cell communication
Recent evidence demonstrates that enzymatically active proteases and glycosidases are present on the surface of some exosomes, 
| Effects of TEC-EVs on kidney injury and repair
Zhang et al reported that in cell culture study, exosomes from hypoxic renal proximal tubular cells (RPTCs) had inhibitory effects on apoptosis of RPTCs following ATP depletion. 40 Intravenous administration of exosomes from normal human kidney tubular cells prevented damage after hypoxic AKI. 56, 57 In contrary to the protective effect, other study found that exosomes from injured TECs accelerated kidney injury through activating macrophage infiltration and activation in tubulointerstitium. 50 Similarly, scratch wounding in TECs induced a significant increase of exosome production, and the secreted exosomes could inhibit wound healing. 58 Thus, diverse biological effects of exosomes from TECs have been described in different models which might depend on the conditions and functional state of the parent cells. 
|

| EVs and endothelial dysfunction and repair
Endothelial cell injury is central to the pathophysiology of acute and chronic kidney injury due to oxygen depletion, reactive oxygen species generation and hyperperfusion. 61, 62 EVs release was enhanced significantly during endothelial injury. In acute vasculitis, higher level of circulating endothelial microvesicles was observed. Importantly, kinin B1 receptor-positive microvesicles induced neutrophil chemotaxis and contribute to inflammatory process. 63 On the other hand, the same group demonstrated that leukocyte-derived microvesicles bearing B1-kinin receptors are enriched in the plasma of vasculitis patients and dock on endothelial cells in the glomerulus. Thus, leukocyte microvesicles transfer functional receptors to endothelial cell and promote kinin-associated inflammation. 64 Moreover, endothelial
EVs levels, especially endothelial microparticles (EMPs) might also be useful biomarkers for chronic kidney disease (CKD) population and haemodialysis patients, which were associated with greater mortality. For example, urinary EV UMOD mRNA levels are progressively elevated from T2DM to DKD groups and correlate with eGFR and ACR levels. 71 We have recently isolated exosome released from podocyte in the urine, the vesicle structure was positive for the markers of both exosome and podocyte, CD9, AQP2 and nephrin.
Further study showed that CD2AP mRNA from exosome was correlated with both kidney function and severity of fibrosis. 72 Importantly, urinary exosomes and exosomal CCL2 mRNA are promising biomarkers reflecting active renal histologic injury and predicting renal function deterioration in IgAN. 73 Moreover, the stability and enrichment of miRNA in exosome make it a promising candidate biomarker for kidney disease. Exosome miRNA was stable despite repeated frozen-thaw cycles and long-term storage. 74 Interestingly, miRNAs were extremely enriched in the urinary exosome subpopulation, but not MVs in hypertensive patients. Low exosomal miR-146a was associated with the presence of albuminuria. 75 MiR-29c from urinary exosome was significantly reduced in CKD patients and inversely correlated with renal fibrosis scores. 76 Besides, the diagnostic potential of exosomal miRNA has also been demonstrated in autosomal dominant polycystic kidney disease (ADPKD), streptozotocin (STZ)-induced diabetic nephropathy animal models, patients with minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS). [77] [78] [79] However, urinary exosomal biomarkers in different types of kidney disease warrant further validation studies.
| CHALLENGES AN D FUTURE DIRE CTION S OF EVS STUDY IN KIDNEY DISEASE
Despite all the promising data regarding EVs' function in kidney disease, more researches are still needed to extend these findings. First of all, as it is technically challenging to obtain a totally pure EV fraction free from non-vesicular components, it is essential to establish comprehensive studies when EV function was studied. Recently, International Society for Extracellular Vesicles (ISEV) reported the minimal experimental requirements that should be used to attribute any specific biological cargo or functions to EVs. 80 More importantly, nearly all results describing the exosome-mediated cellular crosstalk so far are based on the experimental data in vitro or partly in rodent models. The major impediment to mechanistic studies is to clarity how EVs are formed and how to track their origin and destination in vivo. 81 Identifying the tissues or specific cell of origin for circulating EVs may be especially important in understanding their relevance to disease. 81 Although it is possible to isolate tubule exosomes through glomerular and tubule separation, it is still difficult to identify other cell-specific origin of EVs from kidney.
For urinary EV biomarker study, more efforts are necessary to standardize the EVs isolation methods and the nomenclature of EVs, which might help to get more comparable and repeatable data. [81] [82] [83] Importantly, the low purity of EVs obtained from different isolation methods is common. A recent study report that ultracentrifugation followed by size exclusion chromatography (UC-SEC) yielded the most homogenous population of exosomes and less non-vesicle co-precipitated proteins from urine. 84 The optimal method for EV purification is important especially for urine samples from proteinuric nephropathy patients. 85 Besides, large cohort of validation study is necessary for biomarker development and clinic translation. Meanwhile, to determine the cell origin of urinary exosomes and the relevance of candidate biomarker to the development of kidney disease are the critical issues that deserve in-depth consideration. Cell-specific exosome isolation might rely on the specific cell and exosome markers as well as exosome-bound bead and flow cytometry analysis. However, the efficiency and practicability need further investigation. 
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